ESR1 and ovarian endometrioid adenocarcinoma: Abnormal β-catenin protein expression has been identified in ovarian endometrioid adenocarcinoma associated with endometriosis (Stewart et al. 2013), and E2 has been shown to stabilize β-catenin expression through estrogen receptor binding in neuronal cells (Varea et al. 2009).